To explore the molecular mechanisms underlying the anticancer effect of Pbk-CMV-HA-EBP50, western blot analysis was carried out to determine the expression levels of Bcl-2, an anti-apoptosis protein, in the PC cells. This evidence concerns the gene BCL2 and pachyonychia congenita.